Literature DB >> 19633994

A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.

Cecilia Ahlgren1, Kjell Torén, Anders Odén, Oluf Andersen.   

Abstract

Viral infections are probably involved in the pathogenesis of multiple sclerosis (MS). A recent cohort study in the Gothenburg population revealed no change in MS incidence associated with the introduction of the Swedish measles, mumps and rubella vaccination programmes. The aim of the present study was to clarify whether these infections or vaccinations, and two other infections, varicella and infectious mononucleosis, influence MS risk. We performed a population-based case-control study in Gothenburg that included 509 MS cases and 2,067 controls, born 1959-1986. Data on infections and vaccinations were obtained from questionnaires and from child health and school health records. We found no significant associations between measles, mumps, rubella or varicella and MS risk. These results were consistent between the two source materials. Infectious mononucleosis was associated with significantly higher MS risk (odds ratio 2.03, 95% CI 1.52-2.73). Overall, there was no significant association between measles-mumps-rubella (MMR) vaccination and MS risk, while those MMR vaccinated before age ten only were at significantly higher MS risk (odds ratio 4.92, 95% CI 1.97-12.20). Those MMR vaccinated both before and after age ten had intermediate MS risk. Infection with measles, mumps, rubella and varicella did not influence MS risk in contrast to infectious mononucleosis which conferred doubled MS risk. The association with 'early' MMR vaccination only was an isolated finding, limited by a small number of subjects and multiple testing. Most likely this was a chance finding. Future studies could investigate it on an a priori basis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633994     DOI: 10.1007/s10654-009-9367-2

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  37 in total

1.  Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies.

Authors:  M Elian; S Nightingale; G Dean
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  Selective association of multiple sclerosis with infectious mononucleosis.

Authors:  B M Zaadstra; A M J Chorus; S van Buuren; H Kalsbeek; J M van Noort
Journal:  Mult Scler       Date:  2008-01-21       Impact factor: 6.312

3.  Multiple sclerosis after infectious mononucleosis.

Authors:  Trine Rasmussen Nielsen; Klaus Rostgaard; Nete Munk Nielsen; Nils Koch-Henriksen; Sven Haahr; Per Soelberg Sørensen; Henrik Hjalgrim
Journal:  Arch Neurol       Date:  2007-01

4.  Infections in childhood and adolescence in multiple sclerosis. A case-control study.

Authors:  M Grønning; T Riise; G Kvåle; G Albrektsen; R Midgard; H Nyland
Journal:  Neuroepidemiology       Date:  1993       Impact factor: 3.282

5.  Vaccinations and risk of central nervous system demyelinating diseases in adults.

Authors:  Frank DeStefano; Thomas Verstraeten; Lisa A Jackson; Catherine A Okoro; Patti Benson; Steven B Black; Henry R Shinefield; John P Mullooly; William Likosky; Robert T Chen
Journal:  Arch Neurol       Date:  2003-04

6.  Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections.

Authors:  D C Poskanzer; J L Sever; J L Sheridan; L B Prenney
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

7.  Childhood infections and risk of multiple sclerosis.

Authors:  Peter Bager; Nete Munk Nielsen; Kristine Bihrmann; Morten Frisch; Henrik Hjalgrim; Jan Wohlfart; Nils Koch-Henriksen; Mads Melbye; Tine Westergaard
Journal:  Brain       Date:  2004-09-15       Impact factor: 13.501

8.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.

Authors:  J Goverman; A Woods; L Larson; L P Weiner; L Hood; D M Zaller
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

9.  Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications.

Authors:  Hela-Felicitas Petereit; Dirk Reske
Journal:  Cerebrospinal Fluid Res       Date:  2005-06-27

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  19 in total

1.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

Review 2.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

Review 3.  Epstein-barr virus infection and multiple sclerosis: a review.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-06       Impact factor: 4.147

Review 4.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 5.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 6.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

7.  An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Lahiru Handunnetthi; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

Review 8.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682

9.  New studies, technology, and the progress of epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-12       Impact factor: 8.082

10.  Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study.

Authors:  Sreeram V Ramagopalan; Uy Hoang; Valerie Seagroatt; Adam Handel; George C Ebers; Gavin Giovannoni; Michael J Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-01-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.